428 related articles for article (PubMed ID: 29716784)
1. Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial.
Rosenfeld PJ; Dugel PU; Holz FG; Heier JS; Pearlman JA; Novack RL; Csaky KG; Koester JM; Gregory JK; Kubota R
Ophthalmology; 2018 Oct; 125(10):1556-1567. PubMed ID: 29716784
[TBL] [Abstract][Full Text] [Related]
2. Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration.
Yeong JL; Loveman E; Colquitt JL; Royle P; Waugh N; Lois N
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013154. PubMed ID: 33331670
[TBL] [Abstract][Full Text] [Related]
3. Phase ii, randomized, placebo-controlled, 90-day study of emixustat hydrochloride in geographic atrophy associated with dry age-related macular degeneration.
Dugel PU; Novack RL; Csaky KG; Richmond PP; Birch DG; Kubota R
Retina; 2015 Jun; 35(6):1173-83. PubMed ID: 25932553
[TBL] [Abstract][Full Text] [Related]
4. Orally Administered Alpha Lipoic Acid as a Treatment for Geographic Atrophy: A Randomized Clinical Trial.
Kim BJ; Hunter A; Brucker AJ; Hahn P; Gehrs K; Patel A; Edwards AO; Li Y; Khurana RN; Nissim I; Daniel E; Grunwald J; Ying GS; Pistilli M; Maguire MG; Dunaief JL
Ophthalmol Retina; 2020 Sep; 4(9):889-898. PubMed ID: 32418846
[TBL] [Abstract][Full Text] [Related]
5. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
Holekamp N; Wykoff CC; Schmitz-Valckenberg S; Monés J; Souied EH; Lin H; Rabena MD; Cantrell RA; Henry EC; Tang F; Swaminathan B; Martin J; Ferrara D; Staurenghi G
Ophthalmology; 2020 Jun; 127(6):769-783. PubMed ID: 32081489
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11.
Domalpally A; Danis R; Agrón E; Blodi B; Clemons T; Chew E;
Ophthalmology; 2016 Nov; 123(11):2401-2407. PubMed ID: 27448832
[TBL] [Abstract][Full Text] [Related]
7. Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study.
Jaffe GJ; Schmitz-Valckenberg S; Boyer D; Heier J; Wolf-Schnurrbusch U; Staurenghi G; Schmidt-Erfurth U; Holz FG
Am J Ophthalmol; 2015 Dec; 160(6):1226-34. PubMed ID: 26310670
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration: Phase 2b Study.
Heier JS; Ho AC; Samuel MA; Chang T; Riemann CD; Kitchens JW; Slakter JS; Leiderman YI; Spencer R; Williams GA; Hickson-Curran SB; Keane M; Baldassarre JS;
Ophthalmol Retina; 2020 Apr; 4(4):384-393. PubMed ID: 32033908
[TBL] [Abstract][Full Text] [Related]
9. Relationship of Topographic Distribution of Geographic Atrophy to Visual Acuity in Nonexudative Age-Related Macular Degeneration.
Shen LL; Sun M; Ahluwalia A; Young BK; Park MM; Toth CA; Lad EM; Del Priore LV
Ophthalmol Retina; 2021 Aug; 5(8):761-774. PubMed ID: 33212271
[TBL] [Abstract][Full Text] [Related]
10. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
Liao DS; Grossi FV; El Mehdi D; Gerber MR; Brown DM; Heier JS; Wykoff CC; Singerman LJ; Abraham P; Grassmann F; Nuernberg P; Weber BHF; Deschatelets P; Kim RY; Chung CY; Ribeiro RM; Hamdani M; Rosenfeld PJ; Boyer DS; Slakter JS; Francois CG
Ophthalmology; 2020 Feb; 127(2):186-195. PubMed ID: 31474439
[TBL] [Abstract][Full Text] [Related]
11. Increased Fundus Autofluorescence and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GAIN Study.
Biarnés M; Arias L; Alonso J; Garcia M; Hijano M; Rodríguez A; Serrano A; Badal J; Muhtaseb H; Verdaguer P; Monés J
Am J Ophthalmol; 2015 Aug; 160(2):345-353.e5. PubMed ID: 25982972
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials.
Holz FG; Sadda SR; Busbee B; Chew EY; Mitchell P; Tufail A; Brittain C; Ferrara D; Gray S; Honigberg L; Martin J; Tong B; Ehrlich JS; Bressler NM;
JAMA Ophthalmol; 2018 Jun; 136(6):666-677. PubMed ID: 29801123
[TBL] [Abstract][Full Text] [Related]
13. Müller cells and choriocapillaris in the pathogenesis of geographic atrophy secondary to age-related macular degeneration.
Pilotto E; Midena E; Longhin E; Parrozzani R; Frisina R; Frizziero L
Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1159-1167. PubMed ID: 30903311
[TBL] [Abstract][Full Text] [Related]
14. Quantification of Geographic Atrophy Using Spectral Domain OCT in Age-Related Macular Degeneration.
Cleland SC; Konda SM; Danis RP; Huang Y; Myers DJ; Blodi BA; Domalpally A
Ophthalmol Retina; 2021 Jan; 5(1):41-48. PubMed ID: 32679202
[TBL] [Abstract][Full Text] [Related]
15. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.
Jaffe GJ; Westby K; Csaky KG; Monés J; Pearlman JA; Patel SS; Joondeph BC; Randolph J; Masonson H; Rezaei KA
Ophthalmology; 2021 Apr; 128(4):576-586. PubMed ID: 32882310
[TBL] [Abstract][Full Text] [Related]
16. The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration.
Fleckenstein M; Mitchell P; Freund KB; Sadda S; Holz FG; Brittain C; Henry EC; Ferrara D
Ophthalmology; 2018 Mar; 125(3):369-390. PubMed ID: 29110945
[TBL] [Abstract][Full Text] [Related]
17. Progression of Photoreceptor Degeneration in Geographic Atrophy Secondary to Age-related Macular Degeneration.
Pfau M; von der Emde L; de Sisternes L; Hallak JA; Leng T; Schmitz-Valckenberg S; Holz FG; Fleckenstein M; Rubin DL
JAMA Ophthalmol; 2020 Oct; 138(10):1026-1034. PubMed ID: 32789526
[TBL] [Abstract][Full Text] [Related]
18. Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials.
Heier JS; Pieramici D; Chakravarthy U; Patel SS; Gupta S; Lotery A; Lad EM; Silverman D; Henry EC; Anderesi M; Tschosik EA; Gray S; Ferrara D; Guymer R;
Ophthalmol Retina; 2020 Jul; 4(7):673-688. PubMed ID: 32199866
[TBL] [Abstract][Full Text] [Related]
19. Phase 1, dose-ranging study of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in healthy volunteers.
Kubota R; Al-Fayoumi S; Mallikaarjun S; Patil S; Bavik C; Chandler JW
Retina; 2014 Mar; 34(3):603-9. PubMed ID: 24056528
[TBL] [Abstract][Full Text] [Related]
20. Effect of Human Central Nervous System Stem Cell Subretinal Transplantation on Progression of Geographic Atrophy Secondary to Nonneovascular Age-Related Macular Degeneration.
Nittala MG; Uji A; Velaga SB; Hariri AH; Naor J; Birch DG; Spencer R; Leng T; Capela A; Tsukamoto A; Ip M; Sadda SR
Ophthalmol Retina; 2021 Jan; 5(1):32-40. PubMed ID: 32562884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
